Eledon Pharmaceuticals, Inc. (ELDN)
3.41
-0.04
(-1.16%)
USD |
NASDAQ |
Aug 24, 16:00
3.40
-0.01
(-0.29%)
Pre-Market: 09:13
Eledon Pharmaceuticals Shareholders Equity (Quarterly) : 72.03M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.03M |
| March 31, 2026 | 100.46M |
| December 31, 2025 | 136.78M |
| September 30, 2025 | 91.05M |
| June 30, 2025 | 106.03M |
| March 31, 2025 | 114.58M |
| December 31, 2024 | 118.14M |
| September 30, 2024 | 76.06M |
| June 30, 2024 | -8.501M |
| March 31, 2024 | -14.73M |
| December 31, 2023 | 7.208M |
| September 30, 2023 | 91.34M |
| June 30, 2023 | 99.95M |
| March 31, 2023 | 74.79M |
| December 31, 2022 | 84.18M |
| September 30, 2022 | 141.09M |
| June 30, 2022 | 149.38M |
| March 31, 2022 | 156.32M |
| December 31, 2021 | 164.00M |
| September 30, 2021 | 170.75M |
| June 30, 2021 | 178.52M |
| March 31, 2021 | 183.87M |
| December 31, 2020 | 190.60M |
| September 30, 2020 | 21.51M |
| June 30, 2020 | 9.356M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.74M |
| December 31, 2019 | 9.465M |
| September 30, 2019 | 13.37M |
| June 30, 2019 | 16.03M |
| March 31, 2019 | 9.929M |
| December 31, 2018 | 14.49M |
| September 30, 2018 | 18.32M |
| June 30, 2018 | 21.51M |
| March 31, 2018 | 24.30M |
| December 31, 2017 | 19.45M |
| September 30, 2017 | 20.62M |
| June 30, 2017 | 23.44M |
| March 31, 2017 | 23.36M |
| December 31, 2016 | -2.702M |
| September 30, 2016 | 30.26M |
| June 30, 2016 | 38.88M |
| March 31, 2016 | 51.41M |
| December 31, 2015 | 61.72M |
| September 30, 2015 | 71.90M |
| June 30, 2015 | 82.75M |
| March 31, 2015 | 90.90M |
| December 31, 2014 | 103.50M |
| September 30, 2014 | 101.61M |
| June 30, 2014 | 19.73M |
| March 31, 2014 | 25.32M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 20.25B |
| Viking Therapeutics, Inc. | 408.32M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.09M |
| Total Liabilities (Quarterly) | 54.06M |
| Debt to Equity Ratio | 0.0065 |
| Current Ratio | 7.896 |
| Net Debt Paydown Yield | 0.03% |